LIPOPROTEIN (A) LEVELS IN MONOGENIC VERSUS POLYGENIC HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Jain, A. [1 ]
Ewang-Emukowhate, M. [1 ]
Hoshi, N. [1 ]
Omosilade, M. [1 ]
Nair, D. R. [1 ]
机构：
[1] Royal Free Hosp, Dept Clin Biochem, Pond St, London NW32QG, England
来源：
ATHEROSCLEROSIS PLUS | 2021年 / 43卷
关键词：
Polygenic Hypercholesterolemia; Lipoprotein (a); Familial hypercholesterolemia;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] CARDIOVASCULAR RISK OF MONOGENIC VERSUS POLYGENIC CAUSES OF HYPERCHOLESTEROLEMIA
    Brunham, Liam
    Francis, Gordon
    Trinder, Mark
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1834 - 1834
  • [2] Distribution of lipoprotein(a) and interest of Lipoprotein(a) levels as a predictor of occurrence of cardiovascular events in monogenic familial hypercholesterolemia, polygenic familial hypercholesterolemia and diabetics patients
    Del Marmol, Gregoire
    Aksel, Ysar
    Descamps, Olivier
    ACTA CLINICA BELGICA, 2019, 74 : 22 - 22
  • [3] Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically
    Wang, Jian
    Dron, Jacqueline S.
    Ban, Matthew R.
    Robinson, John F.
    McIntyre, Adam D.
    Alazzam, Maher
    Zhao, Pei Jun
    Dilliott, Allison A.
    Cao, Henian
    Huff, Murray W.
    Rhainds, David
    Low-Kam, Cecile
    Dube, Marie-Pierre
    Lettre, Guillaume
    Tardif, Jean-Claude
    Hegele, Robert A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (12) : 2439 - 2445
  • [4] Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
    Trinder, Mark
    Paquette, Martine
    Cermakova, Lubomira
    Ban, Matthew R.
    Hegele, Robert A.
    Baass, Alexis
    Brunham, Liam R.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (05): : 515 - 523
  • [5] Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
    Jacob, Erin
    Hegele, Robert A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (06) : 419 - 426
  • [6] Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
    Erin Jacob
    Robert A. Hegele
    Current Atherosclerosis Reports, 2022, 24 : 419 - 426
  • [7] FAMILIAL HYPERCHOLESTEROLEMIA - MONOGENIC, POLYGENIC OR BOTH?
    Medeiros, Ana Margarida
    Alves, Ana Catarina
    Chora, Joana Rita
    Bourbon, Mafalda
    MEDICINE, 2022, 101 (30)
  • [8] Monogenic, polygenic, and oligogenic familial hypercholesterolemia
    Tada, Hayato
    Nohara, Atsushi
    Kawashiri, Masa-aki
    CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (04) : 300 - 306
  • [9] Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
    Mickiewicz, Agnieszka
    Futema, Marta
    Cwiklinska, Agnieszka
    Kuchta, Agnieszka
    Jankowski, Maciej
    Kaszubowski, Mariusz
    Chmara, Magdalena
    Wasag, Bartosz
    Fijalkowski, Marcin
    Jaguszewski, Milosz
    Humphries, Steve E.
    Gruchala, Marcin
    LIFE-BASEL, 2020, 10 (05):
  • [10] Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia
    Trinder, Mark
    Li, Xuan
    DeCastro, Maria Liza
    Cermakova, Luba
    Sadananda, Singh
    Jackson, Linda M.
    Azizi, Hawmid
    Mancini, G. B. John
    Francis, Gordon A.
    Frohlich, Jiri
    Brunham, Liam R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (04) : 512 - 522
12345